Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition
Autor: | Bai, Yuntao, Kim, Ji Young, Bisunke, Bijay, Jayne, Laura A., Silvaroli, Josie A., Balzer, Michael S., Gandhi, Megha, Huang, Kevin M., Sander, Veronika, Prosek, Jason, Cianciolo, Rachel E., Baker, Sharyn D., Sparreboom, Alex, Jhaveri, Kenar D., Susztak, Katalin, Bajwa, Amandeep, Pabla, Navjot Singh |
---|---|
Zdroj: | In Kidney International December 2021 100(6):1214-1226 |
Databáze: | ScienceDirect |
Externí odkaz: |